Abstract: A soft, flexible, low-density, open-cell, thermoplastic, absorbent foam formed from a foam polymer formula including a balanced amount of a plasticizing agent and a surfactant in combination with a base resin. Thermoplastic elastomers can be added to the foam polymer formula to improve softness, flexibility, elasticity, and resiliency of the resulting foam. The surfactant may be either a single surfactant or a multi-surfactant system. The foam possesses a number of qualities, such as softness and strength, which render the foam particularly suitable for use in a variety of personal care products, medical products, and the like.

Abstract: The invention provides isolated p49/STRAP protein, and isolated nucleic acids encoding a p49/STRAP protein. The inventors have discovered a new protein, named p49/STRAP that is expressed in cardiac tissue and other tissues in mammals. The p49/STRAP protein binds to serum response factor (SRF) and regulates transcription of SRF-responsive genes in the heart. p49/STRAP is also discovered to inhibit tumor cell proliferation, and thus the invention provides a method of inhibiting cancer cell proliferation by contacting the cells with p49/STRAP.

Abstract: Elastic composite laminates are disclosed. The laminates include an elastic member bonded to at least one facing material. In accordance with the present disclosure, an adhesive composition is coextruded with an elastomeric material to form the elastic member. In this manner, the elastic member can be bonded to the facing material in a stretched state without having to apply a separate adhesive layer between the two materials. In one embodiment, the elastic member can be bonded to the facing material according to a pattern that includes bonded areas and non-bonded areas.

Abstract: The present invention relates to ultrathin fluid-absorbent cores comprising a substrate layer, multicomponent superabsorbent particles and an adhesive, wherein the wet SAP shake-out of superabsorbent particles out of the fluid-absorbent core is less than 10% by weight.

Abstract: The present invention relates to ultrathin fluid-absorbent cores comprising a substrate layer, water-absorbent polymer particles and an adhesive, wherein dry SAP shake out of water-absorbent polymer particles out of the fluid-absorbent core is less than 0.6% by weight.

Abstract: The present invention relates to ultrathin fluid-absorbent cores comprising a substrate layer, water-absorbent polymer particles and an adhesive, wherein the water-absorbent polymer particles comprise a basic salt of a polyvalent metal cation and a monovalent carboxylic acid anion on the surface and the wet SAP shake out of water-absorbent polymer particles out of the fluid-absorbent core is less than 10% by weight.

Abstract: Disclosed are dihydroindolone compounds which can modulate the activity of protein tyrosine kinases, a method for preparing the same, and pharmaceutical compositions comprising the same. Also disclosed are use of such compounds and pharmaceutical compositions thereof in the treatment and/or prophylaxis of protein tyrosine kinase associated diseases in an organism, particularly in the treatment and/or prophylaxis of tumors and fibroblast proliferation associated diseases.

Abstract: The invention provides a method of identifying candidate agents to test for treating heart failure involving diastolic impairment, the method comprising: testing an agent to determine whether it (a) binds to serum response factor (SRF), (b) reduces SRF binding to a serum response element (SRE), or (c) reduces SRF protein levels in a cell; wherein if the agent does one or more of (a), (b), and (c), it is identified as a candidate agent.

Abstract: The present invention relates to ultrathin fluid-absorbent cores comprising a substrate layer, water-absorbent polymer particles and an adhesive, wherein the wet SAP shake out of water-absorbent polymer particles out of the fluid-absorbent core is less than 10% by weight.

Abstract: At least a selected microporous membrane is made by a dry-stretch process and has substantially round shaped pores and a ratio of machine direction tensile strength to transverse direction tensile strength in the range of 0.5 to 6.0. The method of making the foregoing microporous membrane may include the steps of: extruding a polymer into a nonporous precursor, and biaxially stretching the nonporous precursor, the biaxial stretching including a machine direction stretching and a transverse direction stretching, the transverse direction including a simultaneous controlled machine direction relax.

Abstract: An application system for applying a solid particle includes an injector housing having a material inlet, a gas inlet, and a material outlet, and an occluder moveably disposed within the injector housing between the gas inlet and the material outlet. The injector housing and the occluder define there between at least one adjustable aperture downstream of the material inlet and in fluid communication with the gas inlet and the material outlet. The aperture has a first open area with the occluder in a first position and a second open area with the occluder in a second position, the second open area being different than the first open area. The system also includes a nozzle having a nozzle inlet coupled to the material outlet and a nozzle outlet, the inlet having a circular cross-section and the outlet having a rectangular cross-section.

Abstract: Absorbent structures that form superabsorbent polymers in situ. The structures include an absorbent material and a fibrous material containing an activating agent. The fibrous material releases the activating agent upon stimulation with an activator, which causes the polymer to become a superabsorbent polymer. The absorbent component is desirably a water-swellable, water-insoluble polymer. The absorbent structures form a superabsorbent composition in situ. Methods of making the activating agent containing fibrous material are provided.

Abstract: An article comprises a stretchable absorbent composite (30) that includes a quantity of superabsorbent particles (32) which are operatively contained within a matrix of elastomeric polymer fibers (34). In particular aspects, the composite article can include at least about 60 wt % of the superabsorbent particles and not more than about 40 wt % of the elastomeric polymer fibers, based on a total weight of the composite. In other aspects, the composite article can provide a high stretchability. Additional aspects can provide a low shake-out. Particular configurations can, for example, provide a stretchability value of at least about 30%. Additional aspects can include a configuration that provides a shake-out value of not more than about 2%. In further aspects, the absorbent composite can include superabsorbent particles having a coating of treatment-material that is thermally processible. Additional aspects can include a treatment-material which is water soluble.

Abstract: An absorbent material formed at least in part of a crosslinked polymer. The absorbent material has a centrifuge retention capacity as determined by a Centrifuge Retention Capacity Test of at least about 20 g/g and a gel bed permeability under load as determined by a Gel Bed Permeability Under Load Test of at least about 300×10?9 cm2 or a free swell gel bed permeability as determined by a Free Swell Gel Bed Permeability Test of at least about 2,500×10?9 cm2. The crosslinked polymer may comprise either at least about 75 weight percent anionic polymer or at least about 75 weight percent cationic polymer. In one embodiment, the cross-linked polymer is surface treated with a water soluble non-cross-linked polymer having a potential for becoming charged opposite that of the cross-linked polymer.

Abstract: An absorbent material formed at least in part of a cross-linked polymer. The absorbent material has a centrifuge retention capacity as determined by a Centrifuge Retention Capacity Test of at least about 20 g/g and a gel bed permeability under load as determined by a Gel Bed Permeability Under Load Test of at least about 300×10?9 cm2 or a free swell gel bed permeability as determined by a Free Swell Gel Bed Permeability Test of at least about 2,500×10?9 cm2. The cross-linked polymer may comprise either at least about 75 weight percent anionic polymer or at least about 75 weight percent cationic polymer. In one embodiment, the cross-linked polymer is surface treated with a water soluble non-cross-linked polymer having a potential for becoming charged opposite that of the cross-linked polymer.

Abstract: A stretchable absorbent composite having a Composite Permeability of about 10 Darcy or more, or about 15 Darcy or more, and Composite Stretchability of about 30% or more, or about 50% or more, or about 100% or more, and a method of making such a stretchable absorbent composite. The stretchable absorbent composite includes a superabsorbent material, an elastomeric material, and, optionally, pulp fibers. More particularly, the stretchable absorbent composite may include between about 30% and about 85% by weight superabsorbent material, between about 5% and about 25% by weight elastomeric material, and between about 10% and about 70% by weight pulp fibers. The stretchability and liquid handling abilities of the stretchable absorbent composite renders the stretchable absorbent composite suitable for incorporation into a variety of absorbent articles, including personal care products, health/medical absorbent articles, and household/industrial absorbent articles, for example.

Abstract: The invention provides a method of identifying candidate agents to test for treating heart failure involving diastolic impairment, the method comprising: testing an agent to determine whether it (a) binds to serum response factor (SRF), (b) reduces SRF binding to a serum response element (SRE), or (c) reduces SRF protein levels in a cell; wherein if the agent does one or more of (a), (b), and (c), it is identified as a candidate agent.

Abstract: The invention provides isolated p49/STRAP protein, and isolated nucleic acids encoding a p49/STRAP protein. The inventors have discovered a new protein, named p49/STRAP that is expressed in cardiac tissue and other tissues in mammals. The p49/STRAP protein binds to serum response factor (SRF) and regulates transcription of SRF-responsive genes in the heart. p49/STRAP is also discovered to inhibit tumor cell proliferation, and thus the invention provides a method of inhibiting cancer cell proliferation by contacting the cells with p49/STRAP.

Abstract: The invention provides isolated p49/STRAP protein, and isolated nucleic acids encoding a p49/STRAP protein. The inventors have discovered a new protein, named p49/STRAP that is expressed in cardiac tissue and other tissues in mammals. The p49/STRAP protein binds to serum response factor (SRF) and regulates transcription of SRF-responsive genes in the heart. p49/STRAP is also discovered to inhibit tumor cell proliferation, and thus the invention provides a method of inhibiting cancer cell proliferation by contacting the cells with p49/STRAP.

Abstract: A battery separator comprises a co-extruded, microporous membrane having at least two layers made of extrudable polymers and having: a uniform thickness defined by a standard deviation of <0.80 microns (?m); or an interply adhesion as defined by a peel strength >60 grams.